Session Information
2009 Midyear Clinical Meeting
Click here to go to the previous page
From Research to Clinical Practice: Pharmacogenomics Principles and Concepts
Track: Educational Sessions (CE)
Program Code: 221-L04
Date: Monday, December 7, 2009
Time: 4:00 PM to 5:00 PM EST
Location: Palazzo M, Level 5
MEETING PLANNING ASSOCIATE:   Click the plus sign to see more detailed information about each speaker.
 Grace Kuo, PharmD, MPH, Associate Professor of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences; and Associate Professor of Family and Preventive Medicine, School of Medicine, University of California, San Diego
PRESENTER(S):   Click the plus sign to see more detailed information about each speaker.
 Grace Kuo, PharmD, MPH, Associate Professor of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences; and Associate Professor of Family and Preventive Medicine, School of Medicine, University of California, San Diego
 Howard McLeod, PharmD, Fred N. Eshelman Distinguished Professor and Director, Institute for Pharmacogenomics and Individualized Therapy, The University of North Carolina
Description
Planned in cooperation with the ASHP Section of Clinical Specialists and Scientists Taskforce on Science
ACPE Activity #204-000-09-221-L04P
1.0 Contact Hour / Knowledge-based
Educational Content: Level 2
Moderator: Grace M. Kuo, PharmD, MPH,
Associate Professor of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences; and Associate Professor of Family and Preventive Medicine, School of Medicine, University of California, San Diego, La Jolla

Presenter: Howard McLeod, PharmD, Fred N. Eshelman Distinguished Professor and Director, Institute for Pharmacogenomics and Individualized Therapy, The University of North Carolina, Chapel Hill, NC

Learning Objectives:

LEARNER OUTCOMES:
  • Describe and define pharmacogenomic concepts and taxonomy.
  • Describe pharmacogenomic principles and the effect on pharmacodynamics.
  • Describe pharmacogenomic principles and the effect on pharmacokinetics.
  • Identify resource databases for obtaining current and updated pharmacogenomic data and information.
  • Identify the key advances that have been made in the Human Genome Project.


Audio Synchronized to PowerPoint
(Code: 221-L04)
Attendee:Free
  
This session is a part of:
Handout Online
View